17:00 Thu 07 May 2020
Mediclinic Intnl plc - Holding(s) in Company
(Incorporated in
Company Number: 08338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88
LEI: 2138002S5BSBIZTD5I60
("Mediclinic", the "Company", or the "Group")
TR-1: Standard form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS |
|
||||||
|
|
||||||
1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: |
|
|
|||||
1b. Please indicate if the issuer is a non- |
|
||||||
Non- |
|
|
|||||
2. Reason for the notification (please mark the appropriate box or boxes with an "X") |
|
||||||
An acquisition or disposal of voting rights |
X |
|
|||||
An acquisition or disposal of financial instruments |
|
|
|||||
An event changing the breakdown of voting rights |
|
|
|||||
Other (please specify): |
|
|
|||||
3. Details of person subject to the notification obligation |
|
||||||
|
|
|
|||||
City and country of registered office (if applicable) |
|
|
|||||
4. Full name of shareholder(s) (if different from 3.) |
|
||||||
|
N/A |
|
|||||
City and country of registered office (if applicable) |
|
|
|||||
5. Date on which the threshold was crossed or reached: |
6th |
|
|||||
6. Date on which issuer notified (DD/MM/YYYY): |
7th |
|
|||||
7. Total positions of person(s) subject to the notification obligation |
|
||||||
|
% of voting rights attached to shares (total of 8. A) |
% of voting rights through financial instruments |
Total of both in % (8.A + 8.B) |
Total number of voting rights of issuervii |
|
||
Resulting situation on the date on which threshold was crossed or reached |
5.01% |
|
5.01% |
737,243,810 |
|
||
Position of previous notification (if applicable) |
4.98% |
|
4.98% |
|
|||
8. Notified details of the resulting situation on the date on which the threshold was crossed or reached |
|||||||||
A: Voting rights attached to shares |
|||||||||
Class/type of ISIN code (if possible) |
Number of voting rights |
% of voting rights |
|||||||
Direct (Art 9 of Directive 2004/109/EC) (DTR5.1) |
Indirect (Art 10 of Directive 2004/109/EC) (DTR5.2.1) |
Direct (Art 9 of Directive 2004/109/EC) (DTR5.1) |
Indirect (Art 10 of Directive 2004/109/EC) (DTR5.2.1) |
||||||
GB00B8HX8Z88 |
36,866,812 |
|
5.01% |
|
|||||
|
|
|
|
|
|||||
|
|
|
|
|
|||||
SUBTOTAL 8. A |
36,866,812 |
5.01% |
|||||||
|
|||||||||
B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a)) |
|||||||||
Type of financial instrument |
Expiration |
Exercise/ |
Number of voting rights that may be acquired if the instrument is exercised/converted. |
% of voting rights |
|||||
|
|
|
|
|
|||||
|
|
|
|
|
|||||
|
|
|
|
|
|||||
|
|
SUBTOTAL 8. B 1 |
|
|
|||||
|
|||||||||
B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b)) |
|||||||||
Type of financial instrument |
Expiration |
Exercise/ |
Physical or cash settlement |
Number of voting rights |
% of voting rights |
||||
|
|
|
|
|
|
||||
|
|
|
|
|
|
||||
|
|
|
|
|
|
||||
|
|
|
SUBTOTAL 8.B.2 |
|
|
||||
|
|||||||||
9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an "X") |
||||
Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer |
|
|||
Full chain of controlled undertakings through which the voting rights and/or the |
|
|||
|
% of voting rights if it equals or is higher than the notifiable threshold |
% of voting rights through financial instruments if it equals or is higher than the notifiable threshold |
Total of both if it equals or is higher than the notifiable threshold |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
10. In case of proxy voting, please identify: |
||||
|
|
|||
The number and % of voting rights held |
|
|||
The date until which the voting rights will be held |
|
|||
|
||||
11. Additional information |
||||
|
||||
Place of completion |
|
Date of completion |
|
About
Mediclinic is an international private healthcare services group, established in
The Group's core purpose is to enhance the quality of life.
Its vision is to be the partner of choice that people trust for all their healthcare needs.
Mediclinic is focused on providing specialist-orientated, multi-disciplinary services across the continuum of care in such a way that the Group will be regarded as the most respected and trusted provider of healthcare services by patients, medical practitioners, funders and regulators of healthcare in each of its markets.
As at
The Company's primary listing is on the
Mediclinic also holds a 29.9% interest in Spire Healthcare Group plc, a leading private healthcare group based in the
For further information, please contact:
Company Secretary, Link Company Matters Limited
+44 (0)20 7954 9569
Investor Relations,
+44 (0)20 3786 8181
Media queries
FTI Consulting
+44 (0)20 3727 1000
+27 (0)21 487 9000
Registered address: 6th Floor,
Website: www.mediclinic.com
Corporate broker:
JSE sponsor (
NSX sponsor (
This information is provided by RNS, the news service of the
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of...
FOR OUR FULL DISCLAIMER CLICK HERE